American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders (3rd ed). APA: Washington, DC.
Basset, A. S., McGillivray, B. C., Jones, B. D. & Tapio Pantzer, J. (1988). Partial trisomy chromosome 5 cosegregating with schizophrenia. Lancet i, 799–801.
Bateson, W. & Punnet, R. G. (1908). Confirmation and extensions of Mendel's principles in other animals and plants. Report to the Evaluation Committee of the Royal Society. Saunders: London.
Bell, J. & Haldane, J. B. S. (1937). The linkage between the genes for colour-blindness and haemophilia in man. Proceedings of the Royal Society of London 123, 119–150.
Brockington, I. F., Kendell, R. E. & Leff, J. P. (1978). Definitions of schizophrenia: concordance and prediction of outcome. Psychological Medicine 8, 387–398.
Brynjolfsson, J., Petursson, H., Sherrington, R. & Gurling, H. (1989). Clinical variation in chromosome 5 linked schizophrenia. Abstracts of First World Congress on Psychiatric Genetics, Poster 26, p. 95, Cambridge.
Byerley, W. F. (1989). Genetic linkage revisited. Nature 340, 340–341.
Charron, D. (1990). Molecular basis of human linkage antigen class II disease associations. B Insulin-dependent diabetes mellitus. In Advances in Immunology, 48, (ed. Dixon, F. J.), pp. 132–143. Academic Press: London.
Detera-Wadleigh, S. D., Goldin, L. R., Sherrington, R., Erio, I., Berretini, C. de M. W., Gurling, H. & Gershon, E. S. (1989). Exclusion of linkage to 5q 11–13 in families with schizophrenia and other psychiatric disorders. Nature 340, 391–393.
Edwards, J. H. (1990). The linkage detection problem. Annals of Human Genetics 54, 253–275.
Egeland, J. A., Gerhard, D. S., Pauls, D. L., Sussex, J. N., Kidd, K. K., Allen, C. R., Hostetter, A. M. & Housman, D. E. (1987). Bipolar affective disorders linked to DNA markers on chromosome II. Nature 325, 783–787.
Gottesman, I. I. & Shields, J. (1972). Schizophrenia and Genetics. Academic Press: New York.
Gurling, H., Sherrington, R. P., Brynjolfsson, J., Read, T., Curtis, D., Baljindur, J., Potter, M. & Petursson, H. (1989). Recent and future molecular genetic research into schizophrenia. Psychopharmacology Bulletin 15, 373–382.
Haldane, J. B. S., Sprunt, A. D. & Haldane, N. M. (1915). Reduplication in mice. Journal of Genetics 5, 133–135.
Iacono, W. G., Basset, A. S. & Jones, B. D. (1988). Eye-tracking dysfunction is associated with partial trisomy chromosome 5 and schizophrenia. Archives of General Psychiatry 45, 1140–1141.
Kelsoe, J. R., Ginns, E. I., Egeland, J. E., Gerhard, D. S., Goldstein, A. M., Bale, S. J., Pauls, D. L., Long, R. T., Kidd, K. K., Conte, G., Housman, D. E. & Paul, S. M. (1989). Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the Old Older Amish. Nature 342, 238–243.
Kennedy, J. L., Giuffra, L. A., Moises, H. W., Cavalli-Sforza, L. L., Pakotis, A. J., Kidd, J. R., Castiglione, C. M., Sjogren, B., Wetterberg, L. & Kidd, K. K. (1988). Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish pedigree. Nature 336, 167–170.
Lander, E. S. (1988). Splitting schizophrenia. Nature 336, 105–106.
Mohr, J. (1954). A study of linkage in man. Opera ex domo biologiae hereditariae humanae Universitatis Hafriensis 33. Munksgaard: Copenhagen.
Morgan, T. H. (1912). Further experiments with mutations in eye-colour of Drosophila: the loss of the orange factor. Journal of the Academy of Natural Sciences of Philadelphia 15, 321–346.
Morton, N. E. (1955). Sequential tests for the detection of linkage. American Journal of Human Genetics 7, 277–318.
Propping, P. & Friedl, W. (1988). Genetic studies of biochemical, pathophysiological and pharmacological factors in schizophrenia. In Nosology. Epidemiology and Genetics of Schizophrenia, vol. 3 (ed. Tsuang, M. T. and Simpson, J. C.), ch. 25, pp. 579–608. In Handbook of Schizophrenia (ed. H. A. Nasrallah). Elsevier: Amsterdam.
Race, R. R. & Sanger, R. (1975). Blood Groups in Man (6th edn). Blackwell: Oxford.
Scriver, C. R., Kaufman, S., Woo, S. L. C. (1989). The hyper-phenylalaninaemias, Vol. 1. ch. 15, pp. 495–546. In The Metabolic Basis of Inherited Disease (6th edition) (ed. Scriver, C. R., Baudet, A. L., Sly, W. S., Valle, D.). McGraw Hill: New York.
Sherrington, R., Brynjolfsson, H. P., Potter, M., Pudleston, K., Barraclough, B., Wasmuth, J., Dobbs, M. & Gurling, H. (1988). Localisation of a susceptibility locus for schizophrenia on chromosome 5. Nature 336, 164–167.
St. Clair, D., Blackwood, D., Muir, W., Baillie, D., Hubbard, A., Wright, A. & Evans, H. J. (1989). No linkage of chromosome 5q 11-q13 markers to schizophrenia in Scottish families. Nature 339, 305–309.
Sturt, E. & McGuffin, P. (1985). Can linkage and marker association resolve the genetic aetiology of psychiatric disorders? Review and argument. Psychological Medicine 15, 455–462.
Weeks, D. E., Lehnor, T., Squires-Wheeler, E., Kaufmann, C. & Ott, J. (1990). Measuring the inflation of the lod score due to its maximation over model parameter values in human linkage analysis. Genetic Epidemiology 7, 237–243.
World Health Organization (1978). Mental Disorders: Glossary and Guide to Their Classification in Accordance with the Ninth Revision of the International Classification of Diseases. WHO: Geneva.
